160.98
+5.82(+3.75%)
Currency In INR
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Employees
1195
First IPO Date
March 10, 2016
| Name | Title | Pay | Year Born |
| Mr. Rajaram Narayanan | MD, Chief Executive Officer & Director | 31.18M | 1968 |
| Mr. Phillip Trott | Assoc. Vice President, Head of Legal & Chief Risk Officer | 840,000 | N/A |
| Mr. Saurav Bhala | Chief Financial Officer | 6.52M | N/A |
| Mr. Ravi Nair | Executive Vice President of Human Resources & Administration | 0 | N/A |
| Mr. Prasad Lad | Vice President of HR & Administration | 0 | N/A |
| Mr. Abhishek Singhal | Head of Investor Relations | 0 | N/A |
| Mr. Vedprakash Ragate | Executive Director | 0 | N/A |
| Mr. Ramesh Kumar Pillai | Corporate Vice President of Ra Qa and Technical Services | 0 | 1965 |
| Ms. Yoshita Vora | Company Secretary & Compliance Officer | 0 | N/A |
Sequent Scientific Limited engages in the animal health business worldwide. The company provides animal health active pharmaceutical ingredients (APIs) and finished dosage formulations in the areas of feed supplements, antibiotics, anthelmintics, antibacterial, anti-protozoal, nutraceuticals, nonsteroidal anti-inflammatory drugs, anti-infectives, and dermatology. It offers analytical solutions that supports API, pharmaceutical, personal care, and nutraceutical organizations, as well as provides method validation, stability, and microbiology for APIs and finished products. The company was formerly known as PI Drugs and Pharmaceuticals Limited and changed its name to Sequent Scientific Limited in October 2009. Sequent Scientific Limited was incorporated in 1985 and is headquartered in Mumbai, India. Sequent Scientific Limited operates as a subsidiary of CA Harbor Investments.